Kagan and Soai Win Nobel Chemistry Prize for Solving Century-Old Molecular Mystery

The Royal Swedish Academy of Sciences announced on Wednesday that the 2026 Nobel Prize in Chemistry will be shared by Henri Kagan of France and Kenso Soai of Japan, honoring their pioneering contributions to asymmetric organic synthesis. The award recognizes two intertwined discoveries—non-linear effects and autocatalysis—that together help explain one of chemistry's most persistent puzzles.

The laureates were selected "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis," according to the citation read in Stockholm. The announcement places the pair at the center of a field that seeks to understand how molecules of a single handedness came to dominate the chemistry of life on Earth.

Heiner Linke, who chairs the Nobel Committee for Chemistry, described the pair's work in sweeping terms during the announcement. "Henri Kagan and Kenso Soai have provided a solution to a chemical mystery that is over a century old: how homochirality can emerge spontaneously," he said. "The chemical reactions they have developed are spectacular."

That "mystery" concerns chirality, the property that gives certain molecules a left- or right-handed form, much like a pair of gloves. In living organisms, this asymmetry is near-total: proteins are built almost exclusively from left-handed amino acids, while the sugars in DNA and RNA are right-handed. How nature settled on this uniform handedness—a state known as homochirality—has baffled scientists since the phenomenon was first described in the nineteenth century.

The two researchers attacked the problem from complementary angles. Kagan's investigations into non-linear effects revealed that asymmetric reactions do not always scale in straightforward ways. In some catalytic processes, a small imbalance in the handedness of a catalyst or product can be sharply amplified rather than diluted, offering a mechanism by which a slight initial bias could grow into an overwhelming preference.

Soai's contribution, meanwhile, demonstrated autocatalysis in action. His laboratory developed reactions in which the product of a chemical transformation accelerates its own formation while simultaneously favoring one handedness over the other. In effect, the reaction feeds on itself, perpetuating and strengthening its own molecular asymmetry without any external instruction.

The practical significance of these findings extends well beyond theory. Asymmetric synthesis is central to the manufacture of pharmaceuticals, agrochemicals and specialty materials, where the two mirror-image forms of a molecule can behave very differently in the body. Thalidomide, a sedative prescribed in the late 1950s and early 1960s, remains the most infamous illustration: one handedness eased morning sickness while the other caused severe birth defects. Better control over chirality translates directly into safer and more effective medicines.

The academy noted that Kagan is affiliated with Université Paris-Sud in Orsay, France, while Soai, who is 95 years old, is associated with the Tokyo University of Science. Their collaboration across continents reflects the international character of modern chemical research, bringing together French and Japanese traditions of physical organic chemistry.

Prize recipients this year will share 12 million Swedish kronor, equivalent to roughly $1.2 million. That sum is awarded regardless of whether the honor goes to a single laureate, a small group of researchers or an organization—a structure intended to ensure that major collaborative achievements are properly recognized.

The chemistry award is the third of this year's Nobel Prizes to be revealed. On Monday, the medicine prize went to three scientists—Karl Deisseroth, Peter Hegemann and Georg Nagel—whose work produced a light-based tool for probing how the brain functions. Tuesday's physics prize honored a researcher's efforts to shed light on a rare class of neutrinos, the elusive particles that stream through matter almost unnoticed.

Attention now turns to the remaining announcements. The literature prize is scheduled for Thursday, followed by the peace prize on Friday and the Nobel Memorial Prize in Economic Sciences next Monday, closing out the annual season of honors.

Last year's chemistry laureates tackled a different but equally ambitious challenge: designing new molecular architectures capable of trapping enormous quantities of gas within their frameworks. That research opened the door to technologies that might one day pull greenhouse gases from the atmosphere or extract water from arid desert air, underscoring how chemistry prizes often bridge foundational questions and practical applications.

The 2026 award carries a symbolic weight of its own. Questions about the origin of biological handedness sit at the crossroads of chemistry, physics and biology, touching on how the first self-replicating molecules might have assembled on the early Earth. By showing how asymmetry can arise and amplify without deliberate design, Kagan and Soai offered a plausible chemical pathway toward the molecular uniformity that all known life depends on.

Their work also carries lessons for chemists seeking to replicate nature's precision in the laboratory. Precision synthesis of single-handed molecules remains a demanding and costly endeavor, and insights into non-linear effects and autocatalytic amplification could inform more efficient industrial processes. Researchers in pharmaceuticals and materials science are likely to continue drawing on these principles for years to come.

For Kagan and Soai, the recognition arrives after decades of patient investigation into reactions that, in Linke's words, are nothing short of spectacular. Their discoveries have reshaped how chemists think about symmetry, self-replication and the deep connection between molecular shape and biological function—a legacy now formally enshrined among science's highest honors.